1. Home
  2. CCCC vs CVEO Comparison

CCCC vs CVEO Comparison

Compare CCCC & CVEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

SELL

Current Price

$3.06

Market Cap

350.6M

Sector

Health Care

ML Signal

SELL

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

SELL

Current Price

$31.50

Market Cap

383.3M

ML Signal

SELL

Company Overview

Basic Information
Metric
CCCC
CVEO
Founded
2015
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
350.6M
383.3M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
CCCC
CVEO
Price
$3.06
$31.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$12.86
★ $41.60
AVG Volume (30 Days)
★ 2.0M
83.2K
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.45
N/A
EPS
★ N/A
N/A
Revenue
★ $35,947,000.00
N/A
Revenue This Year
N/A
$8.49
Revenue Next Year
N/A
$4.02
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 1.02
N/A
52 Week Low
$1.69
$20.06
52 Week High
$5.17
$36.50

Technical Indicators

Market Signals
Indicator
CCCC
CVEO
Relative Strength Index (RSI) 44.23 36.87
Support Level $2.88 $29.79
Resistance Level $3.20 $34.90
Average True Range (ATR) 0.22 1.02
MACD 0.02 -0.16
Stochastic Oscillator 54.54 3.99

Price Performance

Historical Comparison
CCCC
CVEO

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

Share on Social Networks: